VPS72, a member of VPS protein family, can be used as a new prognostic marker for hepatocellular carcinoma.

Jian HuangJin GanJian WangMin ZhengHan Xiao

Published in: Immunity, inflammation and disease (2023)

Therefore, our research shows that VPSs participate in HCC occurrence and development, especially VPS72, which may act as a potential target for HCC treatment and prognosis biomarker.

Keyphrases

risk assessment
protein protein
climate change
binding protein
replacement therapy